ClearPoint Neuro, Inc.
CLPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $8,861 | $9,215 | $8,485 | $7,771 |
| % Growth | -3.8% | 8.6% | 9.2% | – |
| Cost of Goods Sold | $3,261 | $3,659 | $3,353 | $3,009 |
| Gross Profit | $5,600 | $5,556 | $5,132 | $4,762 |
| % Margin | 63.2% | 60.3% | 60.5% | 61.3% |
| R&D Expenses | $3,452 | $3,829 | $3,379 | $3,332 |
| G&A Expenses | $3,186 | $3,388 | $4,082 | $3,229 |
| SG&A Expenses | $7,024 | $7,407 | $7,916 | $7,034 |
| Sales & Mktg Exp. | $3,838 | $4,019 | $3,834 | $3,805 |
| Other Operating Expenses | $400 | $0 | $0 | $0 |
| Operating Expenses | $10,876 | $11,236 | $11,295 | $10,366 |
| Operating Income | -$5,276 | -$5,680 | -$6,163 | -$5,604 |
| % Margin | -59.5% | -61.6% | -72.6% | -72.1% |
| Other Income/Exp. Net | -$607 | -$132 | $155 | $218 |
| Pre-Tax Income | -$5,883 | -$5,812 | -$6,008 | -$5,386 |
| Tax Expense | $8 | $25 | $18 | $0 |
| Net Income | -$5,891 | -$5,837 | -$6,026 | -$5,386 |
| % Margin | -66.5% | -63.3% | -71% | -69.3% |
| EPS | -0.21 | -0.21 | -0.22 | -0.2 |
| % Growth | 0% | 4.5% | -10% | – |
| EPS Diluted | -0.21 | -0.21 | -0.22 | -0.2 |
| Weighted Avg Shares Out | 28,428 | 28,258 | 27,719 | 27,028 |
| Weighted Avg Shares Out Dil | 28,428 | 28,258 | 27,719 | 27,028 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $151 | $226 |
| Interest Expense | $543 | $80 | $0 | $0 |
| Depreciation & Amortization | $66 | $626 | $334 | $471 |
| EBITDA | -$5,274 | -$5,106 | -$5,829 | -$5,133 |
| % Margin | -59.5% | -55.4% | -68.7% | -66.1% |